A U.S. subsidiary of the French multinational pharmaceutical corporation Sanofi SA has agreed to pay $180 million to resolve a dispute with a Taiwanese company over patents aimed at treating a rare neuromuscular disease, ending ongoing arbitrations over royalties.
A U.S. subsidiary of the French multinational pharmaceutical corporation Sanofi SA has agreed to pay $180 million to resolve a dispute with a Taiwanese company over patents aimed at treating a rare neuromuscular disease, ending ongoing arbitrations over royalties.
Carbon Black Market to reach USD 5 33 billion by 2025 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.